Current Ratio of Aptevo Therapeutics Inc. from 31 Mar 2017 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Aptevo Therapeutics Inc. quarterly Current Ratio in % history and change rate from 31 Mar 2017 to 30 Sep 2025.
  • Aptevo Therapeutics Inc. Current Ratio for the quarter ending 30 Sep 2025 was 217%, a 6.2% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Aptevo Therapeutics Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 217% +13% +6.2% 30 Sep 2025
Q2 2025 158% -82% -34% 30 Jun 2025
Q1 2025 148% -127% -46% 31 Mar 2025
Q4 2024 178% -164% -48% 31 Dec 2024
Q3 2024 204% -149% -42% 30 Sep 2024
Q2 2024 240% -114% -32% 30 Jun 2024
Q1 2024 275% -107% -28% 31 Mar 2024
Q4 2023 341% +77% +29% 31 Dec 2023
Q3 2023 353% +148% +72% 30 Sep 2023
Q2 2023 354% +165% +88% 30 Jun 2023
Q1 2023 382% +203% +113% 31 Mar 2023
Q4 2022 264% +76% +40% 31 Dec 2022
Q3 2022 205% -14% -6.6% 30 Sep 2022
Q2 2022 188% -63% -25% 30 Jun 2022
Q1 2022 180% -80% -31% 31 Mar 2022
Q4 2021 189% -99% -34% 31 Dec 2021
Q3 2021 219% +75% +52% 30 Sep 2021
Q2 2021 251% +148% +144% 30 Jun 2021
Q1 2021 259% +133% +105% 31 Mar 2021
Q4 2020 287% +135% +89% 31 Dec 2020
Q3 2020 144% -64% -31% 30 Sep 2020
Q2 2020 103% -207% -67% 30 Jun 2020
Q1 2020 126% -209% -62% 31 Mar 2020
Q4 2019 152% -217% -59% 31 Dec 2019
Q3 2019 208% -223% -52% 30 Sep 2019
Q2 2019 310% -205% -40% 30 Jun 2019
Q1 2019 335% -232% -41% 31 Mar 2019
Q4 2018 369% -225% -38% 31 Dec 2018
Q3 2018 431% -114% -21% 30 Sep 2018
Q2 2018 515% +31% +6.5% 30 Jun 2018
Q1 2018 567% +163% +40% 31 Mar 2018
Q4 2017 594% 31 Dec 2017
Q3 2017 545% 30 Sep 2017
Q2 2017 483% 30 Jun 2017
Q1 2017 405% 31 Mar 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.